Bayer's stock jumps after Supreme Court sides with Roundup weedkiller manufacturerMarket Watch • 06/25/26
Bayer wins Supreme Court case making it harder to sue over glyphosate in Monsanto's RoundupCNBC • 06/25/26
Bayer Not Liable After Man Claimed Weedkiller Caused His Cancer, Supreme Court RulesForbes • 06/25/26
Bayer Welcomes Kacy Perry as New Country Division Head for Crop Science CanadaBusiness Wire • 06/18/26
Federal judge sends Bayer's $7.25 billion Roundup settlement back to Missouri state courtReuters • 06/17/26
Bayer's AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body RegionsBusiness Wire • 06/15/26
EMA Begins Review of Bayer's Asundexian Filing for Stroke PreventionZacks Investment Research • 06/11/26
Bayer Announces Global Consumer Health Leadership Changes to Accelerate GrowthBusiness Wire • 06/08/26
Phase III FIND‑CKD Results Show Bayer's KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non‑Diabetic Chronic Kidney DiseaseBusiness Wire • 06/05/26
Bayer to Present First Full FIND-CKD Results Investigating KERENDIA® (finerenone) in Non-Diabetic Chronic Kidney Disease at ERA 2026Business Wire • 06/02/26
ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head TrialBusiness Wire • 05/30/26